-transparent.png){kind=logo}
ECG parameters in elderly depressed in-patients were assessed during routine desipramine treatment. Significant changes (prolonged PR and PRS intervals and a decreased QTc interval) were found, related only to steady state concentrations of desipramine's major metabolite--2-hydroxy-desipramine. Potentially clinically significant changes developed in 40% of the patients. All serum drug concentrations were within therapeutic limits. Previous assurances about desipramines's cardiac safety in the elderly may need to be re-evaluated.
Related Publications
S P Kutcher, and
K Reid, and
J D Dubbin, and
K I Shulman
November 1986,
Canadian journal of psychiatry. Revue canadienne de psychiatrie,
S P Kutcher, and
K Reid, and
J D Dubbin, and
K I Shulman
January 1981,
European journal of clinical pharmacology,
S P Kutcher, and
K Reid, and
J D Dubbin, and
K I Shulman
July 1992,
Journal of the American Academy of Child and Adolescent Psychiatry,
S P Kutcher, and
K Reid, and
J D Dubbin, and
K I Shulman
September 1981,
The American journal of psychiatry,
S P Kutcher, and
K Reid, and
J D Dubbin, and
K I Shulman
February 1994,
Pediatric emergency care,
S P Kutcher, and
K Reid, and
J D Dubbin, and
K I Shulman
August 1990,
Psychological medicine,
S P Kutcher, and
K Reid, and
J D Dubbin, and
K I Shulman
June 1980,
Clinical pharmacology and therapeutics,
S P Kutcher, and
K Reid, and
J D Dubbin, and
K I Shulman
January 1991,
Psychopharmacology bulletin,
S P Kutcher, and
K Reid, and
J D Dubbin, and
K I Shulman
January 1981,
Psychopharmacology bulletin,
S P Kutcher, and
K Reid, and
J D Dubbin, and
K I Shulman
January 1992,
Brain topography,
